<DOC>
	<DOCNO>NCT01717339</DOCNO>
	<brief_summary>Obstructive sleep apnea ( OSA ) associate endothelial dysfunction development cardiovascular disease . It unclear OSA result endothelial dysfunction , give association OSA obesity , adipose-derived hormone ( adipokines ) likely involve . Leptin , adipokine upregulated patient OSA , show associate deleterious effect vascular function result impaired endothelial function . This proposal direct investigate molecular mechanism endothelial dysfunction OSA patient . We hypothesize endothelial dysfunction associate OSA result molecular alteration within endothelial cell . As part study look NO signaling pathways adipose tissue microvessels normal OSA subject .</brief_summary>
	<brief_title>Sleep Apnea Vascular Function</brief_title>
	<detailed_description />
	<criteria>Non OSA , newly diagnose OSA subject , na√Øve CPAP treatment , age 1865 year , BMI le equal 55 kg/m2 , free chronic disease include diabetes , cardiovascular disease , recruit study . Subjects dyslipidemia hypertension allow participate study . Subjects take antidepressents , anithypertensives allow participate study . Also , subject take beta blocker beta agonist allow participate study . If subject aspirin antiinflammatory medication free know vascular disease depend indication , study doctor may ask subject suspend aspirin antiinflammatory therapy 7 day prior participation study . In event subject stop aspirin antiinflammatory medication , able participate study risk bleed fat biopsy . Body weight &gt; 450 pound ( 204.5kg ) Pregnancy . Anemic ( hemoglobin &lt; 13.5 g/dL men &lt; 12.0 g/dL woman . Postmenopausal Smoking Use chronic Medications ( aspirin , statin , antiinflammatory drug )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>